Jennifer's Shared Resources
![](https://hepatitisc.pocn.com/wp-content/uploads/2024/06/Direct-Acting-Antivirals-Allow-HCV-Treatment-for-Substance-Users-Without-Abstinence.jpg)
Direct-Acting Antivirals Allow HCV Treatment for Substance Users Without Abstinence
Substance use disorders affect roughly 25% of Americans aged 12 and older, with illicit drug use prevalent in 2022. The...
![](https://hepatitisc.pocn.com/wp-content/uploads/2024/05/2024-05-10-poce-hc-img-6.jpeg)
Hepatitis C’s Extrahepatic Complications: A Continuing Health Challenge Despite Advancements in Antiviral Therapies
Hepatitis C, a major health concern caused by the hepatitis C virus, leads to liver cancer and organ damage-related deaths....
![](https://hepatitisc.pocn.com/wp-content/uploads/2024/02/2024-02-image1.jpg)
US Health Guidelines Stress Regular Screening, Integrated ART for HCV/HIV Coinfection
Members and consultants of the US Department of Health and Human Services panel released their recommendations for antiretroviral use in...
![](https://hepatitisc.pocn.com/wp-content/uploads/2024/02/article13.jpeg)
New Report Urges Single-Visit Hepatitis C Testing to Improve Diagnosis and Treatment Outcomes
A report highlights the need to update hepatitis C virus (HCV) testing protocols for better diagnosis and treatment. Currently, about...
![](https://hepatitisc.pocn.com/wp-content/uploads/2024/02/article7.jpeg)
Study Highlights DAAs’ Role in HCV Management
Researchers assessed the management of hepatitis C Virus (HCV) infection, focusing on liver fibrosis and the impact of direct-acting antivirals...
![](https://hepatitisc.pocn.com/wp-content/uploads/2024/02/2024-02-16-image-update.jpg)
Dr. Andrea Cox Discusses Trial on HCV Vaccine, Highlights Need for Prevention Alongside Treatment
In this podcast, Dr. Andrea Cox from Johns Hopkins University School of Medicine discusses her team’s randomized controlled trial that...